# Ozurdex for Macular Edema Post Membrane Peeling

> **NCT01273727** · PHASE2,PHASE3 · COMPLETED · sponsor: **Retina Specialists, PC** · enrollment: 35 (actual)

## Conditions studied

- Epiretinal Membrane
- Cellophane Maculopathy
- Macular Edema
- Retinal Edema

## Interventions

- **DRUG:** Dexamethasone
- **DRUG:** dexamethasone

## Key facts

- **NCT ID:** NCT01273727
- **Lead sponsor:** Retina Specialists, PC
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-06
- **Primary completion:** 2014-04
- **Final completion:** 2014-04
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2015-05-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01273727

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01273727, "Ozurdex for Macular Edema Post Membrane Peeling". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01273727. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*